(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Mat... extract, responds to a press release issued on No...arian company for making false and self-serving st...ences. ,, Dr. Hidvegi stated from his office i...that research on Avemar does not apply to AveULTRA...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNewswir...ve filed on November 16th, 2009 Flibanserin in the...skinesia in Parkinson,s,disease for orphan drug st...y,(EMEA). Levodopa-induced dyskinesia is a complic...son,s and a serious burden to some of those,affect...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswir...e program on one product candidate at an unexpecte...ate AD02 is planned to enter into,Phase II clinica...y,immediately follows the completion of two Phase ...mpany based its fast decision on the first interim...
(Date:11/18/2009)...ists at Queen,s University Belfast are developing ...drugs which will help in the fight against the thr... special gel pads to ,swipe, an individual or crim...by a scanning instrument that can detect the prese...etter, faster decisions to be made in response to ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2...rporated (Nasdaq:,VICL) today reported financial r...venues for the third quarter of 2008 were $0.8 mil...he third quarter of 2007. The net loss,for the thi...hare, compared,with $9.2 million or $0.24 per shar...e first nine months of 2008 were $5.3 million, com...
...p://www.amdl.com ),AMDL, Inc. (Amex: ADL ), annou...and Director, Gary L. Dreher, has retired at the c...been a member of the Company,s leadership,team and...s best wishes to,Mr. Dreher on his retirement., A...ations in Shenzhen, Jiangxi, and,Jilin, China, AMD...
...-PRNewswire-FirstCall/ -- China Sky One,Medical, I...sdaq: CSKI ), a,leading fully integrated pharmace... the People,s Republic of China ("PRC"), today ann...:00 A.M. Eastern Time on November 10,2008 to discu...ning Mr. Yan-qing Liu, Chairman, CEO and Director ...
Other Biology Technology:Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs 2Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs 3Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs 4Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs 5Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs 6AMDL, Inc.'s President & CEO Mr. Gary Dreher Retires 2China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results 2China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results 3Complete 2 channel polarographic oxygen monitoring system from Instech Solomon
XTT (23-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) from Molecular Probes (Invitrogen)
...5) This volume provides excellent background inf...ds for the study of major HIV proteins including: ...uclease H, integrase and protease. Expression of H...s; Tat and Rev assays; HIV/CD4 interactions; trans...
Sheep Anti-Mouse TREM-2 Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: